Effects of a timely therapy with doxycycline on the left ventricular remodeling according to the pre-procedural TIMI flow grade in patients with ST-elevation acute myocardial infarction

Basic Research in Cardiology

Volumn 109, Issue 4, 2014, Pages

  Cerisano, Giampaolo ^a   Buonamici, Piergiovanni ^a   Valenti, Renato ^a   Moschi, Guia ^a   Taddeucci, Enrico ^a   Giurlani, Letizia ^a   Migliorini, Angela ^a   Vergara, Ruben ^a   Parodi, Guido ^a   Sciagrá, Roberto ^b   Romito, Roberta ^c   Colonna, Paolo ^c   Antoniucci, David ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c POLICLINICO   (Italy)

Author keywords

Acute myocardial infarction; Doxycycline; TIMI flow Grade; Ventricular remodeling

Indexed keywords

DOXYCYCLINE; CARDIOVASCULAR AGENT; MATRIX METALLOPROTEINASE INHIBITOR;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT DURATION; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VASCULAR PATENCY; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY STENOSIS; DRUG ADMINISTRATION; DRUG EFFECTS; ENZYMOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; ITALY; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; ITALY; MALE; MATRIX METALLOPROTEINASE INHIBITORS; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84900851371     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-014-0412-2     Document Type: Article

References (42)

1. Clements IP, Christian TF, Higano ST, Gibbons RJ, Gersh BJ (1993) Residual flow to the infarct zone as a determinant of infarct size after direct angioplasty. Circulation 88:1527-1533. doi:10.1161/01.CIR.88.4.1527
2. De Luca G, Parodi G, Sciagrà R, Venditti F, Bellandi B, Vergara R, Migliorini A, Valenti R, Antoniucci D (2013) Preprocedural TIMI flow and infarct size in STEMI undergoing primary angioplasty. J Thromb Thrombolysis. doi:10.1007/s11239-013-0977- x (in press)
3. Ndrepepa G, Kastrati A, Schwaiger M, Mehilli J, Markwardt C, Dibra A, Dirschinger J, Schömig A (2005) Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction. J Nucl Med 46:1782-1788
4. Leoncini M, Bellandi F, Sciagrà R, Maioli M, Toso A, Sestini S, Coppola A, Mennuti A, Dabizzi RP, Pupi A (2004) Use of 99mTc-sestamibi gated SPECT to assess the influence of anterograde flow before primary coronary angioplasty on tissue salvage and functional recovery in acute myocardial infarction. Eur J Nucl Med Mol Imaging 31:1378-1385. doi:10.1007/s00259- 004-1595-9
5. Brodie BR, Stuckey TD, Hansen C, Muncy D (2000) Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol 85:13-18. doi:10.1016/S0002-9149(99)00598-6
6. Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J, Mattos L, Lansky AJ, O'Neill WW, Grines CL (2001) Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 104:636-641. doi:10.1161/hc3101. 093701
7. Garcia-Dorado D, Theroux P, Elizaga J, Galinanes S, Solares J, Riesgo M, Gomez MJ, Garcia-Dorado A, Fernandez Aviles F (1987) Myocardial infarction in the pig heart model: infarct size and duration of coronary occlusion. Cardiovasc Res 21:537-544. doi:10.1093/cvr/21.7.537
8. Reimer KA, Vander Heide RS, Richard VJ (1993) Reperfusion in acute myocardial infarction: effects of timing and modulating factors in experimental models. Am J Cardiol 2:13G-21G. doi:10.1016/0002-9149(93)90102-I
9. Silvain J, Collet JP, Nagaswami C, Beygui F, Edmondson KE, Bellemain-Appaix A, Cayla G, Pena A, Brugier D, Barthelemy O, Montalescot G, Weisel JW (2011) Composition of coronary thrombus in acute myocardial infarction. J Am Coll Cardiol 57:1359-1361. doi:10.1016/j.jacc.2010.09.077
10. Ortiz-Pérez JT, Lee DC, Meyers SN, Davidson CJ, Bonow RO, Wu E (2010) Determinants of myocardial salvage during acute myocardial infarction: evaluation with a combined angiographic and CMR myocardial salvage index. JACC Cardiovasc Imaging 3:491-500. doi:10.1016/j.jcmg.2010.02.004
11. Cerisano G, Buonamici P, Valenti R, Sciagrà R, Raspanti S, Santini A, Carrabba N, Dovellini EV, Romito R, Pupi A, Colonna P, Antoniucci D (2014) Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial. Eur Heart J 35:184-191. doi:10. 1093/eurheartj/eht420
12. Griffin MO, Fricovsky E, Ceballos G, Villarreal FJ (2010) Tetracycline, a pleiotropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 539:C539-C548. doi:10.1152/ajpcell. 00047.2010
13. Prall AK, Longo GM, Mayhan WG, Waltke EA, Fleckten B, Thompson RW, Baxter BT (2002) Doxycycline in patients with abdominal aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 35:923-929. doi:10.1067/mva.2002.123757
14. Garcia RA, Go KV, Villarreal FJ (2007) Effects of timed administration of doxycycline or methylprednisolone on postmyocardial infarction remodeling inflammation and left ventricular remodeling in the rat heart. Mol Cell Biochem 300:159-169. doi:10.1007/s11010-006-9379-0
15. Villarreal FJ, Griffin M, Omens J, Dillmann W, Nguyen J, Covell J (2003) Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. Circulation 108:1487-1492. doi:10.1161/01.CIR. 0000089090.05757.34
16. Schröder R, Dissmann R, Brüggemann T, Wegscheider K, Linderer T, Tebbe U, Neuhaus KL (1994) Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with AMI. J Am Coll Cardiol 24:384-391. doi:10.1016/0735-1097(94)90292-5
17. TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. TIMI Study Group.NEngl J Med 312:932-936. doi:10.1056/NEJM198504043121435
18. Rentrop KP, Cohen M, Blanke H, Phillips RA (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5:587-592. doi:10.1016/S0735-1097(85) 80380-6
19. Ducharme A, Frantz S, Aikava M, Rabkin E, Lindsey M, Rodhe LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55-62. doi:10. 1172/JCI8768
20. Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y (2005) Targeted delection or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 115:599-609. doi:10.1172/JCI22304
21. Mukherjee R, Widener CE, Brinsa TA, Dowdy KB, Scott AA, Sample JA, Hendrick JW, Escobar GP, Joffs C, Lucas DG, Zile MR, Spinale FG (2003) Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation 107:618-625. doi:10. 1161/01.CIR.0000046449.36178.00
22. Kelly D, Cockerill G, Ng LL, Thompson M, Khan S, Samani NJ, Squire LB (2007) Plasma matrix metalloproteinase-9 and left ventricular remodeling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 28:711-718. doi:10.1093/ eurheartj/ehm003
23. Webb CS, Bonnema DD, Ahmed SH, Leonardi AH, McClure CD, Clark LL, Stround RE, Corn C, Finklea L, Zile MR, Spinale FG (2006) Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 114:1020-1027. doi:10. 1161/CIRCULATIONAHA.105.600353
24. Ramamurthy NS, Vernillo AT, Greenwald RA, Lee HM, Sorsa T, Golub LM, Rifkin BR (1993) Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J Bone Miner Res 8:1247-1253. doi:10.1002/jbmr. 5650081013
25. Yaras N, Sariahmetoglu M, Bilginoglu A, Aydemir-Koksoy A, Onay-Besikci A, Turan B, Schulz R (2008) Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol 155:1174-1184. doi:10.1038/bjp.2008.373
26. Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R (2000) Matrix metalloproteinase-2 contributes to ischemia/reperfusion injury in the heart. Circulation 101:1833-1839. doi:10.1161/01.CIR.101.15.1833
27. Donato M, D'Annunzio V, Buchholz B, Miksztowicz V, Carrion CL, Valdez LB, Zaobornyj T, Schreier L, Wikinski R, Boveris A, Berg G, Gelpi J (2010) Role of matrix metalloproteinase-2 in the cardioprotective effect of ischemic postconditioning. Exp Physiol 95:274-281. doi:10.1113/expphysiol.2009.049874
28. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R (2002) Intracellular actions of matrix metalloproteinase- 2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106:1543-1549. doi:10.1161/01.CIR.00000 28818.33488.7B
29. Schulz R (2007) Intracellular targets of matrix metalloproteinase- 2 in cardiac disease: rationale and therapeutic approaches. Annu Rev of Pharmacol Toxicol 47:211-242. doi:10.1146/annurev. pharmtox.47.120505.105230
30. Braunwald E (1997) Heart Disease. A textbook of cardiovascular medicine, 5th edn. WB Saunders Company, Philadelphia, pp 1195-1196
31. Lehrke S, Nazhari R, Durand DJ, Zheng M, Bedja D, Zimmet JM, Schuleri KH, Chi AS, Gabrielson KL, Hare JM (2006) Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res 99:553-560. doi:10.1161/01.RES. 0000238375.88582.d8
32. Cohn JN (1995) Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation 91:2504-2507. doi:10.1161/01.CIR.91.10.2504
33. de Kam PJ, Voors AA, van den Berg MP, van Veldhuisen DJ, Brouwer J, Crijns HJ, Borghi C, Ambrosioni E, Hochman JS, LeJemtel TH, Kingma JH, Sutton MS, van Gilst WH (2000) Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators. J Am Coll Cardiol 36:2047-2053. doi:10.1016/S0735-1097(00)01024-X
34. Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández- Friera L, Mateos A, Fernández-Ortiz A, Garcáa-Ruiz JM, Garcáa-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández- Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Pérez de Prado A, Fernández- Campos MJ, Casado I, Garcáa-Rubira JC, Garcáa-Prieto J, Sanz- Rosa D, Cuellas C, Hernández-Antolán R, Albarrán A, Fernández- Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V (2013) Effect of early metoprolol on infarct size in ST-segmentelevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD- CNIC) trial. Circulation 128:1495-1503. doi:10.1161/ CIRCULATIONAHA.113.003653
35. Bøtker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sørensen HT, Redington AN, Nielsen TT (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375:727-734. doi:10.1016/S0140- 6736(09)62001-8
36. Munk K, Andersen NH, Schmidt MR, Nielsen SS, Terkelsen CJ, Sloth E, Bøtker HE, Nielsen TT, Poulsen SH (2010) Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty: impact on left ventricular function assessed by comprehensive Echocardiography and gated single-photon emission CT. Circ Cardiovasc Imaging 3:656-662. doi:10.1161/CIRCIMAGING.110.957340 (Epub 2010 Sep 8)
37. Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381:166-175. doi:10.1016/S0140- 6736(12)60916-7
38. Heusch G, Kleinbongard P, Skyschally A (2013) Myocardial infarction and coronary microvascular obstruction: an intimate, but complicated relationship. Basic Res Cardiol 108:380. doi:10. 1007/s00395-013-0380-y
39. Longacre LS, Kloner RA, Arai AE, Baines CP, Bolli R, Braunwald E, Downey J, Gibbons RJ, Gottlieb RA, Heusch G, Jennings RB, Lefer DJ, Mentzer RM, Murphy E, Ovize M, Ping P, Przyklenk K, Sack MN, Vander Heide RS, Vinten-Johansen J, Yellon DM (2011) New horizons in cardioprotection: recommendations From the 2010 national heart, lung, and blood institute workshop. Circulation 124:1172-1179. doi:10.1161/ CIRCULATIONAHA.111.032698
40. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R, Working Group of Cellular Biology of Heart of European Society of Cardiology (2010) Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 87:406-423. doi:10.1093/cvr/cvq129
41. Vergés B, Zeller M, Beer JC, Cottin Y, RICO survey working group (2008) Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes. Diabetes Metab 34:10-15. doi:10.1016/S1262-3636 (08)70097-1
42. Van deWerf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 29:2909-2945. doi:10.1093/eurheartj/ ehn416